Connor, Clark & Lunn Investment Management (CC&L)’s Atara Biotherapeutics ATRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,572
| Closed | -$149K | – | 1199 |
|
|
2022
Q3 | $149K | Sell |
1,572
-2,624
| -63% | -$249K | ﹤0.01% | 1021 |
|
|
2022
Q2 | $817K | Buy |
4,196
+2,362
| +129% | +$460K | 0.01% | 665 |
|
|
2022
Q1 | $426K | Buy |
1,834
+1,095
| +148% | +$254K | ﹤0.01% | 811 |
|
|
2021
Q4 | $291K | Buy |
739
+100
| +16% | +$39.4K | ﹤0.01% | 898 |
|
|
2021
Q3 | $286K | Buy |
+639
| New | +$286K | ﹤0.01% | 883 |
|
|
2020
Q2 | – | Sell |
-521
| Closed | -$111K | – | 1010 |
|
|
2020
Q1 | $111K | Buy |
+521
| New | +$111K | ﹤0.01% | 924 |
|